Chronic Kidney Disease on Hemodialysis, Chronic Kidney Disease - Stage V
Conditions
Keywords
Chronic kidney disease, Renal replacement therapy, Clinical outcomes
Brief summary
A descriptive, observational, prospective, multicenter study aimed at describing the main clinical outcomes of patients with chronic kidney disease receiving any form of renal replacement therapy in Mexico.
Interventions
None listed
Sponsors
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Willingness to participate and provision of written informed consent * Diagnosis of chronic kidney disease and treatment with hemodialysis or peritoneal dialysis for ≥3 months * Availability of a medical record containing information on the study variables * Receiving care at one of the participating centers
Exclusion criteria
* Life expectancy \<3 months due to a cause unrelated to chronic kidney disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| All-cause mortality | From enrollment in the study until death from any cause or end of follow-up, assessed up to 3 years. | The occurrence of death from any cause during the follow-up period, as documented in the patient's medical record |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Hospitalizations per patient-year | From enrollment until the end of follow-up, assessed up to 3 years | The number of hospitalizations recorded during the study follow-up, expressed per patient-year |
| Infection rate | From enrollment until the end of follow-up, assessed up to 3 years | The number of documented infection episodes during the follow-up period, as recorded in the medical records, expressed per patient-year. |
Contacts
CONTACTOlynka Vega Vega, MD, MSc
CONTACTYazmin Alejandra Mercado Hernandez, MD
Outcome results
None listed